Ben Atkins | VP, Communications & IR |
Roger Crystal | President, CEO & Director |
David O'Toole | CFO |
Brandon Folkes | Cantor Fitzgerald & Co. |
David Bautz | Zacks Investment Research |
Greetings and welcome to the Opiant Pharmaceuticals' Second Quarter 2020 Earnings Conference Call. [Operator Instructions]. It is now my pleasure to introduce your host, Ben Atkins, Vice President of Communications and Investor Relations for Opiant Pharmaceuticals. Thank you, Mr. Atkins.